Muscle strength · adult lung transplant recipients
1 finding from 1 review
Health‐related quality of life · adult lung transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pathological bone fractures · adult lung transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · adult lung transplant recipients
1 finding from 1 review
Adverse eventsAssessed rejection episodes of lung transplant · adult lung transplant recipients
1 finding from 1 review
Lung function · adult lung transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Muscular strength1 Assessed lumbar strength at seven testing positions · adult lung transplant recipients
1 finding from 1 review
Pathological bone fractures Estimated indirectly through BMD · adult lung transplant recipients
1 finding from 1 review
Death (any cause) · adult lung transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Objective measure of medication adherence: Cholesterol (low‐density lipoprotein) · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Objective measure of medication adherence: Blood pressure · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Combined cardiovascular events · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Adverse events · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Cognitive outcome: satisfaction with treatment · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Cardiovascular mortality · patients with chronic heart failure with preserved ejection fraction
Angiotensin receptor neprilysin inhibitors (ARNIs) showed no clear difference in cardiovascular mortality (RR) Median compared with usual care (moderate certainty).
1 finding from 1 review
Time to first hospitalisation for heart failure during · patients with chronic heart failure with preserved ejection fraction
Angiotensin receptor neprilysin inhibitors (ARNIs) showed no clear difference in heart failure hospitalisation, first (RR) Range of compared with usual care (moderate certainty).
1 finding from 1 review
Hyperkalaemia · patients with chronic heart failure with preserved ejection fraction
Angiotensin receptor neprilysin inhibitors (ARNIs) showed no clear difference in hyperkalaemia Range of compared with usual care (moderate certainty).
1 finding from 1 review
All‐cause mortality (RR) Range of · patients with chronic heart failure with preserved ejection fraction
Angiotensin receptor neprilysin inhibitors (ARNIs) leads to lower all‐cause mortality (RR) Range of compared with usual care (high certainty).
1 finding from 1 review
Quality of life Range of · patients with chronic heart failure with preserved ejection fraction
1 finding from 1 review
no estimate extracted
118 participants
High
Death (any cause) · people with CKD who are overweight or obese
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found